Abstract
The next generation of peptides Pharmaceuticals may push manufacturing processes beyond their limits
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
IMS America Ltd. 1995. Reported in MedAdNews 14 (5):23.
Verlandcr, M., Bachem, C.A., personal communication.
Naude, A. 1993. Peptides—Waiting for Harvest. Chemical Marketing Reporter, SR 14, Intermediates '93.
Neely, M., Mallinckrodt Chemicals, personal communication
Du Vigneau, V., et al. 1954. JACS 76: 3115–3121.
Jones, J. 1992. Amino Acid and Peptide Synthesis, New York: Oxford University Press, p. 60.
Jones, D., ProPeptide SNPE; personal communication.
Persichette, R.A., et al. 1995. JACS 117: 2732–2737.
BioScan, Vol. 8., February 1995.
Point of View Report. 1993. Peptide Therapeutics...Business Opportunities and Threats.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kelley, W. Therapeutic Peptides: The Devil is in the Details. Nat Biotechnol 14, 28–31 (1996). https://doi.org/10.1038/nbt0196-28
Issue Date:
DOI: https://doi.org/10.1038/nbt0196-28
This article is cited by
-
Protecting the patentability of your collaborative research
Nature Biotechnology (1997)